[Efficacy analysis of XXXX and @entity1613 in the remnant stomach].

@entity1 @entity1127 @entity548 @entity5 @entity2580 @entity1613 @entity356 @entity1141
OBJECTIVE: To determine the feasibility and efficacy of endoscopic submucosal dissection(ESD) in treating @entity356 (EGC) and @entity1613 in the remnant stomach of @entity1 after gastrectomy. METHODS: Clinical data of 36 @entity1 with EGC and @entity1613 in remnant stomach undergoing ESD in Endoscopy Center of Zhongshan Hospital from January 2008 to December 2013 were retrospectively analyzed. Operative, postoperative conditions and long-term follow-up of these @entity1 were evaluated. RESULTS: Both the success rate and the complete resection rate were 100%. The average maximum diameter of the @entity5 was 1.5(range 0.6-4.5) cm. During the ESD process, two @entity548 cases were treated successfully by endoscopic hemostasis. The average operation time was 40(10-80) min. The delayed @entity548 developed in 2 cases within 1-3 days after operation, and were also treated successfully by endoscopic hemostasis. There was no perforation or delayed perforation. No emergency surgery was required for the complication. Twelve cases were diagnosed as mild-moderate @entity1141 , 7 cases as high grade intraepithelial @entity5 , 16 cases as @entity1127 , and 1 case as @entity2580 with T1 stage, who underwent operation for resecting gastric stump and lymph node dissection 7 days after ESD without subsequent follow-up. The curative resection rate was 92.7%(35/36). The median follow-up of the remaining 35 @entity1 was 36(6-78) months without discomfort and recurrence under gastroscopy. CONCLUSION: ESD is safe and effective for EGC and @entity1613 in the remnant stomach.
